ProductsPricingResearchSupportPartner

-- / 20 shares

IPO Details

Issue Date

--

Investment/lot

--

Price Range

735

Lot Size

20

IPO Size

₹ 869.08 Cr

IPO Listing Details

Listing On

18 Sep'23

Issue Price

--

Listed Price

₹ 973

Retail Gain/Listing Gain

32.38%

Start date

End date

Allotment of bids

Refund Initiation

Listing on exchange

Jupiter Life Line Hospitals Ltd. is a prominent multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and the western region of India, and has been operating for over 15 years in densely populated micro markets. As of 31st March 2023, they boast a total of 1,194 hospital beds distributed across three hospitals (Source: CRISIL Report), and operate under the "Jupiter" brand in Thane, Pune, and Indore. Additionally, they are in the process of constructing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to house more than 500 beds and commenced construction in April 2023.

According to the CRISIL Report, their Thane and Indore hospitals stand out in the western region of India for offering specialised neuro-rehabilitation services through a dedicated robotic and computer-assisted neuro-rehabilitation center. Furthermore, their company operates one of the limited multi-organ transplant centers in Thane (Source: CRISIL Report). Each of their hospitals in Thane, Pune, and Indore has been certified by the National Accreditation Board for Hospitals & Healthcare Providers (NABH) and has been accredited in the field of medical testing by the National Accreditation Board for Testing and Calibration Laboratories (NABL). Notably, the Thane hospital has previously received both the NABH Safe-I certification and the NABH 'Nursing Excellence' accreditation.

With that, let's take a look at the competitive strengths and risk factors for Jupiter Life Line Hospitals Ltd:

Read More
Track record of operational and financial performance
Read More
Focus on environmental, social and governance (ESG) initiatives
Read More
All-hub-no-spoke’ model with a focus on quality patient care supported by modern infrastructure and technological capabilities
Read More
  • Revenues are significantly dependent on the hospital in Thane.

  • The company is highly dependent on their healthcare professionals including doctors and nurses.

  • The industry is highly regulated and requires them to obtain, renew and maintain statutory and regulatory permits, accreditations, and licenses and comply with applicable safety, health, environmental, labour and other governmental regulations.

  • Strategically expand their footprint in western markets.

  • Pursue strategic inorganic growth opportunities in their focussed micro-markets.

  • Continue to improve the quality of care and invest and employ the latest technology.

Here are the key financials for Jupiter Life Line Hospitals Limited:

Particulars (in Rs. million)

Particulars (in Rs. million)

What are you looking for?
Applying for an IPO for the first time?
Here's a video playlist to help you invest in the Jupiter Life Line Hospitals Limited IPO
How to apply for IPO through ASBA

How to apply for IPO through ASBA

Kotak Securities

00m 59s

Jupiter Life Line Hospitals Ltd IPO FAQs

Jupiter Life Line Hospitals Ltd will list on 2023-09-18.

869.08 is the issue size of Jupiter Life Line Hospitals Ltd IPO.

The price band of Jupiter Life Line Hospitals Ltd IPO is ₹735 to ₹0.

The Jupiter Life Line Hospitals Limited IPO has an issue size of Rs. 869 crores. The IPO opens for subscription on 6th September and closes on 8th September 2023.

KFin Technologies Limited is the registrar for this IPO.

You may read more about Jupiter Life Line Hospitals Limited and its IPO from the company’s red herring prospectus (RHP) here:

Open Demat Account to Invest in any IPO
+91 -

personImage
Open Demat Account to Invest in any IPO
+91 -